| 101 |
23782502 | Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function. | 2013 Dec |
4 |
| 102 |
23877988 | Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study. | 2013 Nov |
2 |
| 103 |
24344941 | Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant. | 2013 Dec |
1 |
| 104 |
22059736 | Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes. | 2012 May |
5 |
| 105 |
22443183 | Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study. | 2012 Sep |
1 |
| 106 |
22512606 | Sitagliptin add-on to low dosage sulphonylureas: efficacy and safety of combination therapy on glycaemic control and insulin secretion capacity in type 2 diabetes. | 2012 May |
3 |
| 107 |
22682949 | Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients. | 2012 Oct |
2 |
| 108 |
22685234 | Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. | 2012 Aug |
1 |
| 109 |
22738299 | The effects of sitagliptin on gastric emptying in healthy humans - a randomised, controlled study. | 2012 Aug |
1 |
| 110 |
22949894 | Dipeptidyl Peptidase IV Inhibitor Improves Insulin Resistance and Steatosis in a Refractory Nonalcoholic Fatty Liver Disease Patient: A Case Report. | 2012 May |
1 |
| 111 |
23054692 | Pharmacokinetics of empagliflozin, a sodium glucose cotransporter-2 (SGLT-2) inhibitor, coadministered with sitagliptin in healthy volunteers. | 2012 Oct |
1 |
| 112 |
23055336 | Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes. | 2012 Nov |
4 |
| 113 |
23061989 | A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function. | 2012 Dec |
2 |
| 114 |
21175268 | Effectiveness of sitagliptin in asian Indian patients with type 2 diabetes-an Indian tertiary diabetes care center experience. | 2011 Jan |
2 |
| 115 |
21226820 | Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes. | 2011 Apr |
2 |
| 116 |
21410627 | The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus. | 2011 Jul |
2 |
| 117 |
21443773 | Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: a case series. | 2011 Mar 28 |
2 |
| 118 |
21738898 | Predictive clinical parameters for the therapeutic efficacy of sitagliptin in korean type 2 diabetes mellitus. | 2011 Apr |
1 |
| 119 |
21923696 | Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial. | 2011 Oct |
3 |
| 120 |
20015525 | Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients. | 2010 Jun |
1 |
| 121 |
20092585 | Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. | 2010 Feb |
1 |
| 122 |
21189532 | [Medication of the month. Sitagliptin-metformin fixed combination (Janumet)]. | 2010 Nov |
1 |
| 123 |
21437074 | Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin. | 2010 Mar 29 |
1 |
| 124 |
21437106 | Clinical utility of fixed combinations of sitagliptin-metformin in treatment of type 2 diabetes. | 2010 Oct 27 |
1 |
| 125 |
19366777 | C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. | 2009 Apr 15 |
1 |
| 126 |
18182122 | Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials. | 2008 Feb |
2 |
| 127 |
18372550 | [Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes]. | 2008 Feb |
1 |
| 128 |
23745054 | Hypoglycemia associated with off-label sitagliptin use. | 2008 |
1 |
| 129 |
17352516 | Sitagliptin. | 2007 |
1 |
| 130 |
18201579 | Sitagliptin phosphate: a DPP-4 inhibitor for the treatment of type 2 diabetes mellitus. | 2007 Dec |
3 |
| 131 |
16912128 | Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. | 2006 Nov |
2 |
| 132 |
17130196 | Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. | 2006 Dec |
2 |
| 133 |
17157112 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. | 2006 Oct |
3 |